The signal molecule, retinoic acid, is a product of vitamin A which helps to instruct how different types of tissue are to be formed in the growing embryo. For the first time, researchers from the Lund University have studied the effects of retinoic acid in relation to how blood cells develop from human stem cells. In the laboratory model, the stem cells are exposed to specific signal molecules, thereby developing into blood-producing cells.
The researchers observed that increased levels of retinoic acid drastically reduced the number of blood cells that could be produced. A reduction in the retinoic acid instead increased the production of blood cells by 300 per cent. On the basis of these results, the team propose a new explanatory model of how retinoic acid affects the embryonic development of blood. The opensource study is published in the journal Stem Cell Reports.
Even if vitamin A is required for a normal pregnancy, the researchers stress that it has long been known that too much vitamin A can be damaging to the foetus, with the risk of foetal malformation and miscarriage. Pregnant women have therefore been recommended to limit their consumption of foods that are high in vitamin A in the form of retinoids, such as liver.
The results show that vitamin A in high doses has a negative effect on blood development. This suggests that there is an additional reason for pregnant women to avoid excessive intake of vitamin A during pregnancy. While the concept that retinoic acid affects blood cell development has been demonstrated in animal models, this is the first time the experiments have been done using human cells.
The team state that the current study is about finding ways of artificially generating blood stem cells for use in blood stem cell transplants to patients with blood disorders and cancers, who do not have access to a suitable donor. They summise that the findings increase the medical community’s understanding of the complexity of the process of blood formation during embryonic development. The team hope that this, together with new future discoveries, will lead to the generation of blood stem cells in the laboratory, which in turn can be used to treat blood disorders and malignancies.
Source: Lund University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.